OR-LATTICE-SEMICONDUCTOR
8.12.2020 22:02:11 CET | Business Wire | Press release
Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today announced the Lattice Mach™-NX FPGA family, the second generation in its successful line of secure control FPGAs. Building on the capabilities of the Lattice MachXO3D™ family announced in 2019, Mach-NX FPGAs deliver heightened security features and the fast, power-efficient processing needed to implement a real-time Hardware Root-of-Trust (HRoT) on future server platforms, as well as computing, communications, industrial, and automotive systems. Mach-NX marks the third FPGA family developed on the Lattice Nexus™ FPGA platform in a year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201208005194/en/
“The race is on between bad actors trying to exploit firmware vulnerabilities and developers designing server platforms with the security features and performance to stop them,” said Patrick Moorhead, president and founder of Moor Insights & Strategy. “Protecting systems better requires a real-time HRoT with support for stronger cryptography algorithms like ECC 384 and new, robust data security protocols like SPDM. I believe technologies like Lattice’s Mach FPGA families can simplify and accelerate implementation of these technologies for server OEMs looking to better secure their platforms against cyberattack and IP theft.”
Esam Elashmawi, Chief Strategy and Marketing Officer at Lattice, added: “Securing systems against unauthorized firmware access goes beyond establishing a HRoT at boot. It also requires that components used to build the system are not compromised as they move through the global supply chain. When combined with the additional protection afforded by our SupplyGuard security service, Lattice Mach-NX FPGAs can protect a system throughout its entire lifecycle: beginning at the time components start moving through the supply chain, through initial product assembly, end-product shipping, integration, and throughout the product’s operational lifetime.”
Building on the system control capabilities of the Mach family, Mach-NX FPGAs combine a secure enclave (an advanced, 384-bit hardware-based crypto engine supporting reprogrammable bitstream protection) with a logic cell (LC) and I/O block. The secure enclave helps secure firmware, and the LC and I/O block enable system control functions such as power management and fan control. Mach-NX FPGAs can verify and install the over-the-air firmware updates that keep systems compliant with evolving security guidelines and protocols. The Mach-NX FPGA’s parallel processing architecture and dual-boot flash memory configuration provide the near instantaneous response times needed to detect and recover from attacks (a level of performance beyond the capabilities of other HRoT platforms like MCUs). Mach-NX FPGAs will support the Lattice Sentry™ solutions stack, a robust combination of customizable embedded software, reference designs, IP, and development tools to accelerate the implementation of secure systems compliant with NIST Platform Firmware Resiliency (PFR) Guidelines (NIST SP-800-193).
Key features of the Mach-NX family include:
- Secure system control – Mach-NX FPGAs’ logic (up to 11K LCs) and high I/O count (up to 379) enable fast and secure system control. Lattice is a long-standing leader in programmable logic for system control. Mach FPGAs have an attach rate of over 80 percent on current shipping server platforms.
- Robust standards and protocol compliance – the Mach-NX FPGAs’ 384-bit hardware crypto engine supports quick-and-easy implementation of leading-edge cryptography like ECC 384 and industry-standard security protocols such as NIST SP-800-193 and MCTP-SPDM . Upcoming server platforms will require support for these protocols.
- End-to-end supply chain protection – Mach-NX FPGAs are supported by the Lattice SupplyGuard™ supply chain security subscription service. SupplyGuard gives OEMs and ODMs peace-of-mind by tracking locked Lattice FPGAs through their entire lifecycle, from the point of manufacture, through transport via the global supply chain, system integration and assembly, initial configuration, and deployment.
- Rapidly customizable – the Lattice Propel™ design environment accelerates design of a customized, PFR-compliant HRoT solution. The tool uses a GUI-based development environment that allows developers to create PFR solutions while minimizing the need to write RTL code.
For More Information
To learn more about the Lattice technologies mentioned above, please visit:
- www.latticesemi.com/Mach-NX
- www.latticesemi.com/LatticeNexus
- www.latticesemi.com/MachXO3D
- www.latticesemi.com/LatticeSentry
- www.latticesemi.com/LatticeSupplyGuard
- www.latticesemi.com/LatticePropel
About Lattice Semiconductor
Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive, and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.
For more information about Lattice, please visit www.latticesemi.com . You can also follow us via LinkedIn , Twitter , Facebook , YouTube , WeChat , Weibo or Youku .
Lattice Semiconductor Corporation, Lattice Semiconductor (& design) and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries.
GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201208005194/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
Andersen Consulting udvider sine kompetencer inden for ledelsesrekruttering med Lansdowne Executive Search18.2.2026 17:08:00 CET | Pressemeddelelse
Andersen Consulting styrker sin humancapital-praksis gennem en samarbejdsaftale med Lansdowne Executive Search, der er en Dublin-baseret virksomhed med speciale i lederrekruttering, midlertidige ledelser og bestyrelsesudnævnelser. Lansdowne Executive Search er en irisk-ejet virksomhed, der blev grundlagt i 2015, og som tilbyder C-level-ledelsesekruttering, deltidsledere og bestyrelsesplaceringer. Som en partnerdrevet boutique-virksomhed er Lansdowne kendt for, at seniorledelsen er tæt involveret i alle kundeprojekter. Virksomheden hjælper kunder med at navigere i komplekse ledelsesovergange og vækststrategier på tværs af en bred vifte af sektorer, herunder finans, byggeindustrien, nonprofit, landbrug, videregående uddannelse, den offentlige sektor samt teknologi, medier og telekommunikation. "God ledelse er afhænger af situationen, og det kræver forståelse af langt mere end blot et CV," sagde Tom Keane, der er partner hos Lansdowne Executive Search. "Samarbejdet med Andersen Consulting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
